Skip to main content
. 2020 Sep 14;6(9):e04797. doi: 10.1016/j.heliyon.2020.e04797

Table 5.

The sensitivity, specificity, positive predictive value, negative predictive value, positive likelihood ratio, and negative likelihood ratio of the screening frailty tool.

Screening frailty tool Sensitivity (95% CI) Specificity (95% CI) PPV (95% CI) NPV (95% CI) LR+ (95% CI) LR- (95% CI)
Clinical Frailty Scale 56.00 (34.93–75.60) 98.41 (95.43–99.67) 82.35 (59.03–93.79) 94.42 (91.57–96.34) 35.28 (10.89–114.26) 0.45 (0.29–0.70)
Simple FRAIL questionnaire 88 (68.78–97.45) 85.71 (79.90–90.37) 44.90 (35.83–54.32) 98.18 (94.91–99.36) 6.61 (4.22–8.99) 0.14 (0.05–0.41)
PRISMA-7 76 (54.87–90.64) 86.24 (80.50–90.81) 42.22 (32.45–52.64) 96.45 (93.10–98.20) 5.52 (3.63–8.40) 0.28 (0.14–0.56)
Time Up and Go Test 72 (50.61–87.93) 82.54 (76.36–87.67) 35.29 (26.88–44.74) 95.71 (92.22–97.67) 4.12 (2.78–6.12) 0.34 (0.18–0.64)
Gérontopôle Frailty Screening Tool 88 (68.78–97.45) 83.6 (77.53–88.58) 41.51 (33.27–50.25) 98.14 (94.79–99.35) 5.37 (3.77–7.64) 0.14 (0.05–0.42)

PPV: positive predictive value; NPV: negative predictive value; LR: likelihood ratio.

Compared with Fried phenotype (CHS criteria) as a reference standard.